Skip to main content
DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.822
+0.023 (2.90%)
Nov 21, 2024, 11:24 AM EST - Market open

DarioHealth Revenue

DarioHealth had revenue of $7.42M in the quarter ending September 30, 2024, with 111.00% growth. This brings the company's revenue in the last twelve months to $23.05M, down -2.09% year-over-year. In the year 2023, DarioHealth had annual revenue of $20.35M, down -26.41%.

Revenue (ttm)
$23.05M
Revenue Growth
-2.09%
P/S Ratio
1.24
Revenue / Employee
$78,408
Employees
294
Market Cap
25.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202320.35M-7.30M-26.41%
Dec 31, 202227.66M7.14M34.82%
Dec 31, 202120.51M12.94M170.76%
Dec 31, 20207.58M17.00K0.22%
Dec 31, 20197.56M165.00K2.23%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Equillium 45.91M
Allurion Technologies 34.75M
Pulmatrix 10.01M
Lipocine 7.92M
Marker Therapeutics 5.40M
GeoVax Labs 3.09M
IGC Pharma 1.18M
Revenue Rankings

DRIO News

More News